Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9-10
pubmed:dateCreated
2008-2-18
pubmed:abstractText
Intestinal epithelial cells (IEC) have adapted to the presence of commensal bacteria through a state of tolerance that involves a limited response to lipopolysaccharide (LPS). Low or absent expression of two LPS receptor molecules, the myeloid differentiation (MD)-2 receptor, and toll-like receptor (TLR)4 was suggested to underlie LPS tolerance in IEC. In the present study we performed transfections of TLR4 and MD-2 alone or combined in different IEC lines derived from intestinal cancer (Caco-2, HT-29, and SW837). We found that LPS responsiveness increased more than 100-fold when IEC were transfected with MD-2 alone, but not TLR4. The release of interleukin (IL)-8, but also the expression of cyclooxygenase (Cox-)2 and the related secretion of prostaglandin (PG)E2 were coordinately stimulated by LPS in IEC transfected with MD-2 alone. Supernatants collected from MD-2-transfected IEC supported LPS activation of naïve HT-29, providing additional support to the concept that MD-2 alone endows IEC with LPS responsiveness. LPS responsiveness detected at concentrations as low as 110 pg/ml, and maximal values obtained by 10 ng/ml were clearly beyond those evoked by classical stimuli as IL-1beta. In polarized cells, apical LPS stimulation was markedly more efficient than basolateral. Our data contradict previous opinion that both TLR4 and MD-2 limit IEC response to LPS, and emphasize the prominent role of MD-2 in intestinal immune responses to Gram-negative bacteria.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anthracenes, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2, http://linkedlifedata.com/resource/pubmed/chemical/Dinoprostone, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-8, http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides, http://linkedlifedata.com/resource/pubmed/chemical/Lymphocyte Antigen 96, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B, http://linkedlifedata.com/resource/pubmed/chemical/Pyridines, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/SB 203580, http://linkedlifedata.com/resource/pubmed/chemical/TLR4 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Toll-Like Receptor 4, http://linkedlifedata.com/resource/pubmed/chemical/anthra(1,9-cd)pyrazol-6(2H)-one
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0024-3205
pubmed:author
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
82
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
519-28
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:18215718-Anthracenes, pubmed-meshheading:18215718-Caco-2 Cells, pubmed-meshheading:18215718-Cell Line, Tumor, pubmed-meshheading:18215718-Cells, Cultured, pubmed-meshheading:18215718-Cyclooxygenase 2, pubmed-meshheading:18215718-Dinoprostone, pubmed-meshheading:18215718-Dose-Response Relationship, Drug, pubmed-meshheading:18215718-Enzyme Inhibitors, pubmed-meshheading:18215718-Epithelial Cells, pubmed-meshheading:18215718-Flow Cytometry, pubmed-meshheading:18215718-Gene Expression, pubmed-meshheading:18215718-HT29 Cells, pubmed-meshheading:18215718-Humans, pubmed-meshheading:18215718-Imidazoles, pubmed-meshheading:18215718-Interleukin-8, pubmed-meshheading:18215718-Intestines, pubmed-meshheading:18215718-Lipopolysaccharides, pubmed-meshheading:18215718-Lymphocyte Antigen 96, pubmed-meshheading:18215718-Mitogen-Activated Protein Kinases, pubmed-meshheading:18215718-Monocytes, pubmed-meshheading:18215718-NF-kappa B, pubmed-meshheading:18215718-Pyridines, pubmed-meshheading:18215718-RNA, Messenger, pubmed-meshheading:18215718-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:18215718-Toll-Like Receptor 4, pubmed-meshheading:18215718-Transfection
pubmed:year
2008
pubmed:articleTitle
MD-2 controls bacterial lipopolysaccharide hyporesponsiveness in human intestinal epithelial cells.
pubmed:affiliation
INSERM U538, Centre Hospitalo-Universitaire Saint Antoine, Paris, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't